R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Clinical trial NCT00045123 · UNKNOWN

Trial details

NCT number: NCT00045123
Sponsor: Myrexis Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2002-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.